Approval for Sleep Apnea, MASH, CKD Tirzepatide (Zepbound) originally approved for weight loss now also holds FDA approval for the treatment of moderate to severe obstructive sleep apnea in adults with obesity
To maintain weight loss after GLP-1, we suggest 150-300 minutes of moderate activity weekly (e.g., 30 minutes, 5 days) per CDC guidelines
The broader 2026 context matters: as of May 2026, the FDA has proposed regulatory changes affecting compounded semaglutide and tirzepatide, with a public comment period closing June 29, 2026
The GLP-1 Insurance Coverage Checker dramatically simplifies the process for patients by saving them time with a quick, easy-to-use online tool
Benefits of Compounded Semaglutide While Ozempic is a great option, some patients may benefit from compounded semaglutide, which is a tailored version mixed to meet individual needs
How Much Weight Can You Lose on Ozempic or a GLP-1 Drug